Global Animal Vaccine Adjuvant Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Animal Vaccine Adjuvant Market Research Report 2024
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combinationthese are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
According to MRAResearch’s new survey, global Animal Vaccine Adjuvant market is projected to reach US$ 496.5 million in 2033, increasing from US$ 330 million in 2022, with the CAGR of 6.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Animal Vaccine Adjuvant market research.
Globally, dog and cat ownership is gaining popularity, especially after the pandemic. Such an increase in the rate of pet ownership across the world is expected to boost the market's growth. The increasing animal health expenditure by owners to ensure better diagnosis and treatment and increasing pet ownership are expected to positively impact the veterinary vaccine adjuvants market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Animal Vaccine Adjuvant market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Croda
SEPPIC
SDA BIO
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
Segment by Type
Oral
Subcutaneous
Intramuscular
Others
Livestock Vaccines
Companion Animals Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Animal Vaccine Adjuvant report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Animal Vaccine Adjuvant market is projected to reach US$ 496.5 million in 2033, increasing from US$ 330 million in 2022, with the CAGR of 6.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Animal Vaccine Adjuvant market research.
Globally, dog and cat ownership is gaining popularity, especially after the pandemic. Such an increase in the rate of pet ownership across the world is expected to boost the market's growth. The increasing animal health expenditure by owners to ensure better diagnosis and treatment and increasing pet ownership are expected to positively impact the veterinary vaccine adjuvants market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Animal Vaccine Adjuvant market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Croda
SEPPIC
SDA BIO
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
Segment by Type
Oral
Subcutaneous
Intramuscular
Others
Segment by Application
Livestock Vaccines
Companion Animals Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Animal Vaccine Adjuvant report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source